Health ❯Healthcare ❯Medical Research ❯Clinical Trials

Oncology

WCLC 2025: Combination Approaches Redraw EGFR-Mutant NSCLC Care

Fresh phase 3 readouts at WCLC 2025 steer practice toward tailored combination regimens.

ASCO Conference Showcases Lifestyle-Adapted Immunotherapy and Promising Cancer Vaccines

FDA Reviews Pembrolizumab for Transformative Head and Neck Cancer Treatment